---
schema_version: "secwatch.filing_event.v1"
accession: "0001570562-25-000094"
form_type: "8-K"
ticker: "EOLS"
cik: "0001570562"
company_name: "Evolus, Inc."
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:40:52.557422+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Evolus Q2 revenue $69.4M (+4% YoY); cuts FY2025 guidance to $295-305M; CEO appointed PFO, CMO departing

## Summary
- Q2 net revenue $69.4M, up 4% YoY; GAAP op loss $10.2M vs $7.7M loss YoY; non-GAAP op loss $7.9M vs $1.1M income.
- FY2025 revenue guidance reset to $295-305M (11-15% growth); non-GAAP op expenses $208-213M with $25M savings.
- Evolysse filler delivered $9.7M revenue in Q2, strongest filler launch quarter in over a decade.
- CEO David Moatazedi appointed as Principal Financial Officer; CMO Tomoko Yamagishi-Dressler departing Aug 22, no disagreement.
- Expects meaningful profitability in Q4 2025 and annual profitability from 2026; 15% Evolysse tariff minimal impact.

## SEC filing metadata
- accession: 0001570562-25-000094
- form_type: 8-K
- ticker: EOLS
- cik: 0001570562
- company_name: Evolus, Inc.
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1570562/000157056225000094/0001570562-25-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1570562/000157056225000094/eols-20250801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001570562-25-000094
- JSON: https://secwatch.observer/filing/0001570562-25-000094.json
- Plain text: https://secwatch.observer/filing/0001570562-25-000094.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.